Benchling Customers Transform R&D with Modern Software
Building the Foundation for R&D Success
At the Benchtalk Summit last month, two Benchling customers, Kata Lawler, Business Analyst at Rubius Therapeutics, and Shane Flannelly-King, then-IT Lead at Bioverativ, discussed how they use Benchling to accelerate their cell and protein therapeutics research. Moderated by Benchling’s own Lauren Shields, Head of Customer Success East, Kata and Shane discussed their Benchling journeys in three stages.
Identifying the Need for a New Solution
For Shane, his teams’ usage of their legacy notebook and registration systems was very low, so he knew Bioverativ needed a solution that the scientists actually saw value in using. “The scientific teams were looking for a solution that was more intuitive, easier to use, and provided the sort of connections between experiments that you get in Benchling where you’re able to have bi-directional links whenever an experiment is referenced,” says Shane. For Kata, she knew Rubius needed an informatics solution that was “scalable, extensible, configurable, queryable, and reportable” to support the company’s rapid growth.
Rollout and Implementation Advice
Shane emphasized that for a software implementation to be successful, you need to have “the right working group of representatives from each of the scientific groups together to determine what you’re looking for and then to continue working with you.” Kata’s advice for teams was to “understand what an achievable goal is and frame your implementation and rollout around that… get the right stakeholders in those meetings and then move things forward in an incremental basis.” The bottom line they both agreed on: don’t have too many cooks in the kitchen!
Major Successes and Future Goals
Kata’s big success with Benchling was finally having “the ability to easily query a lot of data we were capturing, and the ability to show dashboards to upper management so they can have oversight without having to go through the minutiae of manually curating data.” For Shane, a big accomplishment was “the deployment of the large molecule registry and getting the buy-in of the large molecule scientists” after Bioverativ’s scientific teams came off of a registry that failed to take off with staff. Shane speaks for his scientific teams when he says the registry puts them “in a position to work easier and faster, and that’s what they really appreciate.”
Read More About Benchtalk Summit 2019
- Highlights from Benchtalk Summit 2019
- Benchling Workshops: Advanced Molecular Biology Features and Integration Capabilities
Want to learn about more about the Benchling Platform?